Latest news
Loading news…
BioVex is a biotechnology company developing and commercializing biological treatments for cancer and infectious diseases.
BioVex was acquired by Amgen in 2011 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Oxton, York, United Kingdom
3
professional contacts at BioVex
Contact execs at BioVex →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to BioVex
Loading news…
FAQs about BioVex
People who checked this page also checked these
Browse the full Acquirezy directory.